-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Everolimus in Ependymoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Ependymoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Everolimus in Ependymoma Drug Details: Everolimus (Afinitor, Votubia, RAD001) is an ester...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TERTiNT in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TERTiNT in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TERTiNT in Solid Tumor Drug Details: TERTiNT is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Alzheimer's Disease Drug Details: Buntanetap (ANVS-401 (Posiphen))...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CC-95775 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CC-95775 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CC-95775 in Solid Tumor Drug Details: CC-95775 (FT-1101) is under development for...
-
Product Insights
NewColonoscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Colonoscopes Pipeline Market Report Overview A Colonoscope is a forward-viewing endoscope designed for examination of the entire colon and terminal ileum. A Colonoscope consists of a long and thin flexible tube having a miniature camera and light source at its distal end. The device consists of a tip housing, a flexible insertion tube, and a cord that connects the light source and the tip housing. The distal part of the insertion tube is flexible enough to allow the device to...
-
Product Insights
NewGelesis Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Gelesis Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Gelesis Inc (Gelesis) is a biotechnology company that develops a novel category of potential therapies for GI-related chronic diseases such as obesity, NAFLD/NASH, IBD and type 2 diabetes. Gelesis is headquartered in Boston, Massachusetts, the US. GlobalData's Medical Devices company profile report, “Gelesis Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their...
-
Product Insights
NewAqua Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Aqua Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aqua Medical Inc, is a biotechnology company that develops vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. The company is headquartered in United States. GlobalData's Medical Devices company profile report, “Aqua Medical Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lanadelumab in Angioedema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lanadelumab in Angioedema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lanadelumab in Angioedema Drug Details: Lanadelumab (Takhzyro) recombinant, fully human, monoclonal antibody...